DEVELOPMENT AND ANAYSIS OF A CYSTIC FIBROSIS SPECIFIC ANTIBIOGRAM
Authors: E. Claire Elson, PharmD, BCPPS1; Ellen Meier, CPNP, APRN2; Doug Swanson, MD3; Rangaraj Selvarangan, BVSc, PhD, D(ABMM)4; Megan Gripka, MT(ASCP)SM4; Christopher M Oermann, MD2
1Department of Pharmacy, Children’s Mercy Kansas City, 2401 Gillham Rd. Kansas City, MO 64108, United States of America
2Department of Pulmonary Medicine, Children’s Mercy Kansas City, 2401 Gillham Rd. Kansas City, MO 64108, United States of America
3Department of Infectious Disease, Children’s Mercy Kansas City, 2401 Gillham Rd. Kansas City, MO 64108, United States of America
4Department of Pathology and Laboratory Medicine, Children’s Mercy Kansas City, 2401 Gillham Rd. Kansas City, MO 64108, United States of America
Corresponding Author: E. Claire Elson, PharmD, BCPPS
Department of Pharmacy
2401 Gillham Rd. Kansas City, MO 64108
United States of America
ecelson@cmh.edu
Running Title: Cystic Fibrosis Specific Antibiogram
Key Words: Cystic Fibrosis, Pulmonology (general), Antibiotic Therapy